Wilson Sonsini Goodrich & Rosati advised Rubedo Life Sciences on the transaction. Rubedo Life Sciences (Rubedo), a biopharmaceutical company, announced it closed a $40M Series A...
Rubedo’s $40 Million Series A Financing Round
Mezo’s $21 Million Fundraising
Wilson Sonsini Goodrich & Rosati represented Pantera Capital in the transaction. Mezo announced the closing of a $21 million fundraising led by Pantera Capital. Other investors in the...
Harvey’s Acquisition of Mirage
Wilson Sonsini Goodrich & Rosati represented Mirage in the transaction. A generative AI company, Harvey announced the acquisition of Mirage. Following the acquisition, Mirage’s founders will...
Kumquat Biosciences’ $1.2 Billion Collaboration and License Agreement with Takeda
Wilson Sonsini Goodrich & Rosati advised Kumquat Biosciences on the transaction. Kumquat Biosciences, a leader in translating breakthrough science into first-in-class therapeutics, announced a strategic and...
D3 Bio’s $62 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati represented the investors in the transaction. D3 Bio, Inc, a clinical-stage biotechnology announced its closing of a $62 million Series A financing...
Kumquat Biosciences’ $1.2 Billion Collaboration and License Agreement with Takeda
Wilson Sonsini Goodrich & Rosati advised Kumquat Biosciences on the transaction. Kumquat Biosciences, a leader in translating breakthrough science into first-in-class therapeutics, announced a strategic and...
D3 Bio’s $62 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati represented the investors in the transaction. D3 Bio, Inc, a clinical-stage biotechnology announced its closing of a $62 million Series A financing...
Albemarle’s $2.3 Billion Depositary Shares Offering
Cravath Swaine & Moore and Troutman Pepper Hamilton Sanders advised Albemarle Corporation on the offering, and Davis Polk & Wardwell advised the representatives of the several...
Collaborative Robotics’ $100 Million Series B Financing Round
Wilson Sonsini Goodrich & Rosati advised Cobot on the transaction. Collaborative Robotics (Cobot), a leader in the development of practical collaborative robots, announced the completion of...
Obsidian’s $160.5 Million Series C Financing Round
Wilson Sonsini Goodrich & Rosati advised investor Novo Holdings on the transaction. Obsidian Therapeutics, Inc. (Obsidian), a clinical-stage biotechnology company, announced it closed an oversubscribed $160.5...
BurnBot’s $20 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati advised BurnBot on the transaction. BurnBot announced it has secured $20 million in financing to expand its mechanized vegetation management and...
Floreo’s Acquisition of Autism Eyes
Wilson Sonsini Goodrich & Rosati advised Floreo on the transaction. Floreo, a leading behavioral therapy virtual reality (VR) company, announced it has acquired Autism Eyes, an...